SOTK — Sono-Tek Corporation

Sono-Tek Corporation Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Q2 Revenue: $5.16 million, a slight increase from $5.13 million in Q1 and marking the sixth consecutive quarter over $5 million.
• First Half Revenue: Record high of $10.3 million, up from $10.19 million year-over-year.
• Net Income: Q2 net income rose 27% to $431,000 ($0.03 per share) compared to $340,000 in Q2 2025. First half net income increased 36% to $917,000 ($0.06 per share).
• Gross Profit: Q2 gross profit increased 3% to $2.6 million, with a gross profit margin of 50%.
• Cash Position: Strong balance sheet with $10.6 million in cash and no debt.
• Backlog: Solid backlog of $11.2 million, indicating strong future revenue potential.

2. Strategic Updates and Business Highlights

• Diversification Strategy: Significant growth in the medical device sector, with medical market sales increasing 150% year-over-year to $1 million, driven by balloon coating systems.
• Product Development: Continued investment in R&D, with $1.3 million spent in the first half of 2026. The company is focusing on larger, more complex systems to increase average selling prices (ASP).
• Market Expansion: Strong performance in Asia, particularly China, where sales increased by 153% year-over-year.
• OEM Partnerships: New partnerships in the optics sector, which may enhance market entry and knowledge.

3. Forward Guidance and Outlook

• Revenue Growth: Guidance for modest revenue growth for the full fiscal year, reflecting ongoing caution due to market adjustments in clean energy and tariff policies.
• Sales Projections: Anticipation of continued strong performance in Q3, potentially exceeding Q4 due to a shipment delay from Q2.
• Long-Term Growth: Confidence in long-term growth prospects driven by the successful implementation of high ASP platforms and ongoing demand in the medical device industry.

4. Bad News, Challenges, or Points of Concern

• Clean Energy Sector Decline: Anticipated decline in clean energy orders this year, which could impact overall revenue despite diversification efforts.
• U.S./Canada Sales Decrease: Sales in the U.S./Canada decreased by 22% year-over-year due to slowing momentum in the clean energy sector.
• Competitive Pressures: Ongoing competition from lower-cost manufacturers, particularly in China, although Sono-Tek's quality has allowed it to maintain a premium position.

5. Notable Q&A Insights

• Medical Device Market: The company has successfully penetrated the Chinese market, with local manufacturers opting for Sono-Tek's systems over domestic competitors due to quality concerns.
• Application Engineering Model: The forward-deployed engineering approach is seen as a key differentiator, enhancing customer relationships and potentially leading to higher margins and recurring revenue.
• Market Dynamics: The semiconductor market shows promise, with increased interest following a successful trade show, indicating potential for future growth in that sector.
• Backlog Recognition: Most of the current backlog will contribute to revenue in FY 2027, with only a small percentage expected to ship in the current fiscal year.

Overall, Sono-Tek Corporation demonstrates solid financial performance and strategic advancements, particularly in the medical device sector, while facing challenges in the clean energy market and competitive pressures. The company remains optimistic about its growth trajectory and market opportunities.